Inventor · disambiguated record
Jay Schneider
Also filed as: SCHNEIDER JAY · SCHNEIDER JAY S
12 granted patents·10 pending applications·212 citations·filing 1999–2020
91Inventor score
Top patents by PatentIndex Score
22 records- 0197US7160913B2Methods and kit for treating Parkinson's diseaseUNIV JEFFERSON·Filed 2003·Granted Jan 9, 2007·110 cites·15 claims
- 0293US8193225B2Isoxazole amides, derivatives and methods of chemical induction of neurogenesisSCHNEIDER JAY·Filed 2007·Granted Jun 5, 2012·37 cites·13 claims
- 0392US8318951B2Stem cell differentiating agents and uses thereforOLSON ERIC N·Filed 2011·Granted Nov 27, 2012·20 cites·3 claims
- 0492US7981935B2Stem cell differentiating agents and uses thereforUNIV TEXAS·Filed 2008·Granted Jul 19, 2011·20 cites·16 claims
- 0584US10874749B2Gene therapies for neurodegenerative disorders targeting ganglioside biosynthetic pathwaysUNIV JEFFERSON·Filed 2016·Granted Dec 29, 2020·2 cites·14 claims
- 0684US6551993B1Partial agonists at the glycine modulatory site of the NMDA receptor for treating cognitive dysfunctionUNIV JEFFERSON·Filed 2000·Granted Apr 22, 2003·18 cites·7 claims
- 0777US7414034B2Treatment of Parkinson's disease with oligonucleotidesUNIV JEFFERSON·Filed 2004·Granted Aug 19, 2008·4 cites·24 claims
- 0866US2007129412A1Methods for treating parkinson's diseaseUNIV JEFFERSON·Filed 2006·Application pending·0 cites
- 0966US2007093503A1Methods and kit for treating parkinson's diseaseUNIV JEFFERSON·Filed 2006·Application pending·0 cites
- 1065US2021213142A1Gene therapies for neurodegenerative disorders targeting ganglioside biosynthetic pathwaysUNIV JEFFERSON·Filed 2020·Application pending·0 cites
- 1163US2014364467A1Chemical inducers of neurogenesisUNIV TEXAS·Filed 2014·Application pending·0 cites
- 1261US8686012B2Stem cell differentiating agents and uses thereforUNIV TEXAS·Filed 2012·Granted Apr 1, 2014·0 cites·10 claims
- 1358US8778940B2Chemical inducers of neurogenesisSCHNEIDER JAY·Filed 2012·Granted Jul 15, 2014·0 cites·15 claims
- 1454US9394558B2Methods for extraction and purification of gangliosidesSCHNEIDER JAY S·Filed 2012·Granted Jul 19, 2016·1 cites·17 claims
- 1553US2016082026A1Ganglioside Transmucosal FormulationsLZ THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 1649US2022226357A1Methods for treating neurodegenerative disordersUNIV JEFFERSON·Filed 2020·Application pending·0 cites
- 1747US9221800B2Isoxazole treatments for diabetesUNIV TEXAS·Filed 2014·Granted Dec 29, 2015·0 cites·52 claims
- 1844US8722716B2Isoxazole treatments for diabetesUNIV TEXAS·Filed 2012·Granted May 13, 2014·0 cites·21 claims
- 1943US2014309179A1Treatment of Glaucoma and Other Retinopathies with GangliosidesLZ THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 2040US2012220544A1Ganglioside Transmucosal FormulationsSCHNEIDER JAY S·Filed 2012·Application pending·0 cites
- 2134US2012220543A1Treatment of Glaucoma and Other Retinopathies with GangliosidesSCHNEIDER JAY S·Filed 2012·Application pending·0 cites
- 2229US2003060436A1Treatment of parkinson's disease with oligonucleotidesCLIFFORD KENT WEBER ESQ·Filed 1999·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jay Schneider files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →